Lamivudine News and Research

RSS
Long-term TDF ‘promising’ in Chinese HBV patients after multiple antiviral failures

Long-term TDF ‘promising’ in Chinese HBV patients after multiple antiviral failures

New AGA guideline provides guidance to prevent HBV reactivation

New AGA guideline provides guidance to prevent HBV reactivation

Age and HBsAg level predict NA-induced HBeAg seroconversion durability

Age and HBsAg level predict NA-induced HBeAg seroconversion durability

Tenofovir stems treatment-induced kidney toxicity in HBV-related chronic hepatitis

Tenofovir stems treatment-induced kidney toxicity in HBV-related chronic hepatitis

Long-term TDF therapy offers sustained HBV suppression without resistance

Long-term TDF therapy offers sustained HBV suppression without resistance

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Three-drug regimen taken during pregnancy prevents mother-to-child HIV transmission

Three-drug regimen taken during pregnancy prevents mother-to-child HIV transmission

FDA approves ViiV Healthcare's Triumeq tablets for treatment of HIV-1 infection

FDA approves ViiV Healthcare's Triumeq tablets for treatment of HIV-1 infection

Antiviral therapy can reduce risk of liver cancer in patients with chronic hepatitis B infection

Antiviral therapy can reduce risk of liver cancer in patients with chronic hepatitis B infection

Dolutegravir drug offers added benefit in HIV patients

Dolutegravir drug offers added benefit in HIV patients

European Commission approves ViiV Healthcare's Tivicay for treatment of HIV infected adults

European Commission approves ViiV Healthcare's Tivicay for treatment of HIV infected adults

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

Gilead Sciences gets FDA approval for once-daily single tablet HIV-1 regimen Complera

More AIDS-defining illnesses and severe side effects occur with appropriate comparator therapy

More AIDS-defining illnesses and severe side effects occur with appropriate comparator therapy

Key HIV drug prices continue to fall, but newer medicines still priced too high

Key HIV drug prices continue to fall, but newer medicines still priced too high

WHO's new HIV treatment guidelines call for immediate ART for HIV-infected children

WHO's new HIV treatment guidelines call for immediate ART for HIV-infected children

New WHO guidelines recommend earlier treatment for people living with HIV

New WHO guidelines recommend earlier treatment for people living with HIV

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

CIHR, CMAJ honour five Canadians for health research excellence

CIHR, CMAJ honour five Canadians for health research excellence

Patients with drug-resistant HIV can safely achieve viral suppression without NRTIs

Patients with drug-resistant HIV can safely achieve viral suppression without NRTIs

Discovery provides clues for potentially eliminating HIV infection in children

Discovery provides clues for potentially eliminating HIV infection in children